CIBC Private Wealth Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $135K | Sell |
|
|||||
|
2025
Q2 | $145K | Buy |
|
|||||
|
2025
Q1 | $62.4K | Buy |
|
|||||
|
2024
Q4 | $55.5K | Hold |
|
|||||
|
2024
Q3 | $63.2K | Hold |
|
|||||
|
2024
Q2 | $71.6K | Sell |
|
|||||
|
2024
Q1 | $110K | Sell |
|
|||||
|
2023
Q4 | $776K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $361K | Hold |
|
|||||
|
2022
Q2 | $335K | Hold |
|
|||||
|
2022
Q1 | $346K | Sell |
|
|||||
|
2021
Q4 | $425K | Sell |
|
|||||
|
2021
Q3 | $643K | Sell |
|
|||||
|
2021
Q2 | $2.64M | Sell |
|
|||||
|
2021
Q1 | $3.75M | Buy |
|
|||||
|
2020
Q4 | $929K | Sell |
|
|||||
|
2020
Q3 | $527K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $207K | Buy |
|
|||||
|
2019
Q4 | $267K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $23K | Sell |
|
|||||
|
2018
Q1 | $24K | Buy |
|